AnaptysBio, Inc. (0HFQ)
LSE
53.84
-0.76 (-1.38%)
Real-time Data
07:00 AM
Day's Range
53.8456.74
52 wk Range
19.8273.09
Financial Statements - 0HFQ - AnaptysBio, Inc.
Net Income
-1.49M▼ 70.6%
EBITDA
-1.49M▼ 68.9%
Free Cash Flow
-5.57M▼ 126.1%
Income Statement
| Period Ending | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|
| Sales | - | - | - | - |
| Cost of Goods | - | - | - | - |
| Gross Profit | - | - | - | - |
 Operating Expense | - | - | - | - |
| Operating Income | -1.50M | -889K | -1.19M | -1.41M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | 8K | 100K | - |
| Pre Tax Income | -1.49M | -877.23K | -1.07M | -1.32M |
| Income Tax | 0 | 0 | 0 | 0 |
| Net Income | -1.49M | -877.23K | -1.07M | -1.32M |
| EPS Basic | - | -0.0005 | -0.0009 | -0.0012 |
| EPS Diluted | - | -0.0005 | -0.0009 | -0.0012 |
| Basic Shares Outstanding | - | 1.61B | 1.24B | 1.07B |
| Diluted Shares Outstanding | - | 1.61B | 1.24B | 1.07B |
| Ebit | - | - | - | - |
| Ebitda | -1.49M | -887.18K | -1.19M | -1.41M |
| Net Income Continuous Operations | - | - | - | - |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
